Cargando…

Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis

INTRODUCTION: Adrenomedullin (AM) is secreted by breast cancer cells and increased by hypoxia. It is a multifunctional peptide that stimulates angiogenesis and proliferation. The peptide is also a potent paracrine stimulator of osteoblasts and bone formation, suggesting a role in skeletal metastases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siclari, Valerie A, Mohammad, Khalid S, Tompkins, Douglas R, Davis, Holly, McKenna, C Ryan, Peng, Xianghong, Wessner, Lisa L, Niewolna, Maria, Guise, Theresa A, Suvannasankha, Attaya, Chirgwin, John M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303191/ https://www.ncbi.nlm.nih.gov/pubmed/25439669 http://dx.doi.org/10.1186/s13058-014-0458-y

Ejemplares similares

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
por: Juárez, Patricia, et al.
Publicado: (2017)

Role of bone-anabolic agents in the treatment of breast cancer bone metastases
por: Suvannasankha, Attaya, et al.
Publicado: (2014)

Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
por: Dunn, Lauren K., et al.
Publicado: (2009)

The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis
por: Lontos, Konstantinos, et al.
Publicado: (2018)

Regulation of Postnatal Trabecular Bone Formation by the Osteoblast Endothelin A Receptor
por: Clines, Gregory A, et al.
Publicado: (2011)

Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis
por: Dejhansathit, Siroj, et al.
Publicado: (2019)

FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells
por: Suvannasankha, Attaya, et al.
Publicado: (2015)

Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
por: Mohammad, Khalid S., et al.
Publicado: (2009)

Combination of Adrenomedullin with Its Binding Protein Accelerates Cutaneous Wound Healing
por: Idrovo, Juan-Pablo, et al.
Publicado: (2015)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

Diagnostic value of mid-regional pro-Adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review
por: Corr, Michael Paul, et al.
Publicado: (2022)

Multifocal Gastric Ulcers Caused by Diffuse Large B Cell Lymphoma in a Patient With Significant Weight Loss
por: Gromski, Mark A., et al.
Publicado: (2016)

A protocol for a systematic review and meta-analysis of the diagnostic accuracy of mid-regional pro-adrenomedullin in predicting invasive bacterial infection in children
por: Corr, Michael, et al.
Publicado: (2020)

Adrenomedullin and tumour angiogenesis
por: Nikitenko, L L, et al.
Publicado: (2006)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

Adrenomedullin and cardiovascular diseases
por: Wong, Hoi Kin, et al.
Publicado: (2012)

Pro-adrenomedullin as prognostic biomarker in the sepsis
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition
por: ZHOU, CHUANG, et al.
Publicado: (2015)

CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells
por: Clark, Ashley J., et al.
Publicado: (2021)

Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma
por: Liu, Enze, et al.
Publicado: (2023)

An Angiogenic Role for Adrenomedullin in Choroidal Neovascularization
por: Sakimoto, Susumu, et al.
Publicado: (2013)

Adrenomedullin: a vasodilator to treat sepsis?
por: Pugin, Jérôme
Publicado: (2014)

Adrenomedullin Haploinsufficiency Predisposes to Secondary Lymphedema
por: Nikitenko, Leonid L, et al.
Publicado: (2013)

The role of adrenomedullin in the pathogenesis of gastric cancer
por: Qiao, Fuhao, et al.
Publicado: (2017)

Adrenomedullin in COVID-19 induced endotheliitis
por: Wilson, Darius Cameron, et al.
Publicado: (2020)

Adrenomedullin: an important participant in neurological diseases
por: Li, Feng-Jiao, et al.
Publicado: (2020)

Significance of adrenomedullin and the role of adrecizumab in sepsis
por: Nair, Abhijit
Publicado: (2021)

Adrenomedullin: Not Just Another Gastrointestinal Peptide
por: Martínez-Herrero, Sonia, et al.
Publicado: (2022)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein-coupled receptor
por: Babin, Katie M., et al.
Publicado: (2023)

Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin(2) G protein–coupled receptor
por: Babin, Katie M., et al.
Publicado: (2023)

Accelerated Bone Regeneration by Adrenomedullin 2 Through Improving the Coupling of Osteogenesis and Angiogenesis via β-Catenin Signaling
por: Wang, Feng, et al.
Publicado: (2021)

A role for adrenomedullin in the pathogenesis of alveolar edema
por: Eisenhut, Michael
Publicado: (2006)

Correlation of Adrenomedullin Concentrations with Knee Osteoarthritis Grade
por: Liu, Linghua, et al.
Publicado: (2016)

Signalling by CGRP and Adrenomedullin in the Cerebellum and Other Systems
por: Poyner, David, et al.
Publicado: (2001)

The mechanism of action of the adrenomedullin-binding antibody adrecizumab
por: Geven, Christopher, et al.
Publicado: (2018)

Adrenomedullin in Sepsis: Finally, a Friend or an Enemy?
por: Ajith Kumar, AK
Publicado: (2020)

Adrenomedullin Therapy in Moderate to Severe COVID-19
por: Kita, Toshihiro, et al.
Publicado: (2022)

Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
por: Wright, Laura E., et al.
Publicado: (2016)

Targeting the osteosarcoma cancer stem cell
por: Siclari, Valerie A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9h34t0fpo2c8lsfqi4kekbp9ef